Gliotoxin-mediated suppression of innate and adaptive immune functions directed against Listeria monocytogenes

References

• Tomee JF, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476–484
   Google Scholar
• Waring P, Eichner RD, Mullbacher A. The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med Res Rev 1988; 8: 499–524
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Chi J, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005; 73: 635–637
   PubMed Web of Science ®Google Scholar
• Watanabe A, Kamei K, Sekine T, et al. Immunosuppressive substances in Aspergillus fumigatus culture filtrate. J Infect Chemother 2003; 9: 114–121
   PubMedGoogle Scholar
• Tsunawaki S, Yoshida LS, Nishida S, et al. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 2004; 72: 3373–3382
   Google Scholar
• Nishida S, Yoshida LS, Shimoyama T, et al. Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase. Infect Immun 2005; 73: 235–244
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LR, Wang J, Le T. Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats. Inflamm Bowel Dis 2002; 8: 159–167
   PubMed Web of Science ®Google Scholar
• Herfarth H, Brand K, Rath HC, et al. Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 2000; 120: 59–65
   PubMed Web of Science ®Google Scholar
• Wichmann G, Herbarth O, Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol 2002; 17: 211–218
   PubMed Web of Science ®Google Scholar
• Yamada A, Kataoka T, Nagai K. The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett 2000; 71: 27–32
   PubMed Web of Science ®Google Scholar
• Braithwaite AW, Eichner RD, Waring P, et al. The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol 1987; 24: 47–55
   PubMed Web of Science ®Google Scholar
• Suen YK, Fung KP, Lee CY, et al. Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization. Free Radic Res 2001; 35: 1–10
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhao A, Goping G, et al. Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells. Toxicol Sci 2000; 54: 194–202
   PubMed Web of Science ®Google Scholar
• Barsig J, Kaufmann SH. The mechanism of cell death in Listeria monocytogenes-infected murine macrophages is distinct from apoptosis. Infect Immun 1997; 65: 4075–4081
   PubMed Web of Science ®Google Scholar
• Eichner RD, Waring P, Geue AM, et al. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J Biol Chem 1988; 263: 3772–3777
   PubMed Web of Science ®Google Scholar
• Pahl HL, Krauss B, Schulze-Osthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183: 1829–1840
   PubMed Web of Science ®Google Scholar
• Liu ZG, Hsu H, Goeddel DV, et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996; 87: 565–576
   PubMed Web of Science ®Google Scholar
• Arlt A, Vorndamm J, Breitenbroich M, et al. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 2001; 20: 859–868
   PubMed Web of Science ®Google Scholar
• Baust H, Schoke A, Brey A, et al. Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappaB independent mechanisms. Oncogene 2003; 22: 8786–8796
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141–179
   PubMed Web of Science ®Google Scholar
• Waring P, Eichner RD, Mullbacher A, et al. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem 1988; 263: 18493–18499
   PubMed Web of Science ®Google Scholar
• Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4: 812–823
   PubMed Web of Science ®Google Scholar
• Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211–220
   PubMed Web of Science ®Google Scholar
• Hauf N, Goebel W, Fiedler F, et al. Listeria monocytogenes infection of P388D1 macrophages results in a biphasic NF-kappaB (RelA/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by IkappaBalpha and IkappaBbeta degradation. Proc Natl Acad Sci U S A 1997; 94: 9394–9399
   PubMed Web of Science ®Google Scholar
• Jones S, Portnoy DA. Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O. Infect Immun 1994; 62: 5608–5613
   Google Scholar
• Pamer EG. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 1994; 152: 686–694
   Google Scholar
• Harty JT, Bevan MJ. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992; 175: 1531–1538
   PubMed Web of Science ®Google Scholar
• Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997; 158: 4229–4236
   PubMed Web of Science ®Google Scholar
• Skoberne M, Schenk S, Hof H, Geginat G. Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes. J Immunol 2002; 169: 1410–1418
   Google Scholar
• Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693–1702
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Geginat G, Nichterlein T, Kretschmar M, et al. Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua. J Immunol 1999; 162: 4781–4789
   PubMed Web of Science ®Google Scholar
• Janda J, Schoneberger P, Skoberne M, et al. Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products. J Immunol 2004; 173: 5644–5651
   PubMed Web of Science ®Google Scholar
• Kwok LY, Lutjen S, Soltek S, et al. The induction and kinetics of antigenspecific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J Immunol 2003; 170: 1949–1957
   PubMed Web of Science ®Google Scholar
• Sutton P, Newcombe NR, Waring P, et al. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 1994; 62: 1192–1198
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Alexopoulou L, Episkopou V, et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184: 1397–1411
   PubMed Web of Science ®Google Scholar
• Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003; 19: 59–70
   PubMed Web of Science ®Google Scholar
• Stanzani M, Orciuolo E, Lewis R, et al. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 2005; 105: 2258–2265
   PubMed Web of Science ®Google Scholar
• Delhalle S, Blasius R, Dicato M, et al. A beginner's guide to NFkappaB signaling pathways. Ann N Y Acad Sci 2004; 1030: 1–13
   PubMed Web of Science ®Google Scholar
• Kroll M, Arenzana-Seisdedos F, Bachelerie F, et al. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol 1999; 60: 689–698
   Google Scholar
• Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78: 761–771
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323–350
   PubMed Web of Science ®Google Scholar
• Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994; 12: 735–773
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1–23
   PubMed Web of Science ®Google Scholar